Introduction Current and developing mast cell therapeutics are reliant on small molecule
drugs and biologics, but few are truly selective for mast cells. Most have cellular and disease …

Lenalidomide is an IMiD drug which has been associated with a variety of potential immune
related complications. We describe the case of a patient with newly diagnosed multiple …

Systemic mastocytosis (SM) is a rare blood disorder that can affect multiple body organs.
There are some patients of SM with coexpression of hematological neoplasm designated in …

A 53-year-old man presented with asymptomatic, dusky reddish nodules on his trunk, which
had persisted for 7 years. Histological findings showed nodular to diffuse dermal infiltration …

Mastocytosis represents a clonal, neoplastic proliferation of morphologically and
immunophenotypically abnormal mast cells, organized in multifocal clusters, in one or more …

Systemic mastocytosis (SM) characterized by focal or diffuse infiltrates of neoplastic mast
cells can range from indolent cutaneous disease to aggressive systemic disease. Skin …

Mastocytosis is a heterogeneous group of disorders in which mast cells exhibit clonal
proliferation that infiltrates one or more organs. In cutaneous mastocytosis, the mast cells …